- Home
- EMBC vs MPLT Comparison
EMBC vs MPLT Comparison
Compare EMBC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- MPLT
- Stock Information
- Founded
- EMBC 1924
- MPLT 2018
- Country
- EMBC United States
- MPLT United States
- Employees
- EMBC N/A
- MPLT N/A
- Industry
- EMBC Medical/Dental Instruments
- MPLT Biotechnology: Pharmaceutical Preparations
- Sector
- EMBC Health Care
- MPLT Health Care
- Exchange
- EMBC Nasdaq
- MPLT Nasdaq
- Market Cap
- EMBC 803.0M
- MPLT 700.6M
- IPO Year
- EMBC N/A
- MPLT 2025
- Fundamental
- Price
- EMBC $14.50
- MPLT $13.11
- Analyst Decision
- EMBC Buy
- MPLT Strong Buy
- Analyst Count
- EMBC 2
- MPLT 4
- Target Price
- EMBC $18.50
- MPLT $31.00
- AVG Volume (30 Days)
- EMBC 374.6K
- MPLT 256.5K
- Earning Date
- EMBC 11-25-2025
- MPLT 12-05-2025
- Dividend Yield
- EMBC 4.15%
- MPLT N/A
- EPS Growth
- EMBC 18.26
- MPLT N/A
- EPS
- EMBC 1.42
- MPLT N/A
- Revenue
- EMBC $1,102,500,000.00
- MPLT N/A
- Revenue This Year
- EMBC N/A
- MPLT N/A
- Revenue Next Year
- EMBC N/A
- MPLT N/A
- P/E Ratio
- EMBC $10.18
- MPLT N/A
- Revenue Growth
- EMBC N/A
- MPLT N/A
- 52 Week Low
- EMBC $9.20
- MPLT $12.96
- 52 Week High
- EMBC $21.48
- MPLT $20.86
- Technical
- Relative Strength Index (RSI)
- EMBC 56.37
- MPLT N/A
- Support Level
- EMBC $13.61
- MPLT N/A
- Resistance Level
- EMBC $14.81
- MPLT N/A
- Average True Range (ATR)
- EMBC 0.62
- MPLT 0.00
- MACD
- EMBC 0.05
- MPLT 0.00
- Stochastic Oscillator
- EMBC 75.16
- MPLT 0.00
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
About MPLT MapLight Therapeutics Inc. Common Stock
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.